BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38159645)

  • 21. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
    Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propranolol vs. steroids in the treatment of infantile hemangiomas: A meta-analysis.
    You Y; Li Y; Xiao Y; Zhang J
    Mol Clin Oncol; 2021 Aug; 15(2):156. PubMed ID: 34178327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta Blockade as Treatment for Intracranial Infantile Hemangioma: Case Report and Literature Review.
    Kang E; Friedman N; Mamoun I; Tamburro J; Golden A
    Pediatr Neurol; 2016 Jun; 59():13-7. PubMed ID: 27068061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subglottic hemangioma: Understanding the association with facial segmental hemangioma in a beard distribution.
    McCormick AA; Tarchichi T; Azbell C; Grunwaldt L; Jabbour N
    Int J Pediatr Otorhinolaryngol; 2018 Oct; 113():34-37. PubMed ID: 30174006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed-onset of multiple cutaneous infantile hemangiomas due to propranolol: a case report.
    Porcel Chacón R; del Boz González J; Navarro Morón J
    Pediatrics; 2015 Apr; 135(4):e1064-6. PubMed ID: 25780066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propranolol for Treatment of Genital Infantile Hemangioma.
    Tran C; Tamburro J; Rhee A; Golden A
    J Urol; 2016 Mar; 195(3):731-7. PubMed ID: 26400030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infantile Hemangiomas: Pathogenesis and Review of Propranolol Use.
    Laken PA
    Adv Neonatal Care; 2016 Apr; 16(2):135-42. PubMed ID: 26945282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemangiomas of the nasal tip treated with propranolol.
    Ben-Amitai D; Halachmi S; Zvulunov A; Raveh E; Kalish E; Lapidoth M
    Dermatology; 2012; 225(4):371-5. PubMed ID: 23428617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of propranolol for complicated infantile hemangiomas.
    Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
    Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.
    Aly MM; Hamza AF; Abdel Kader HM; Saafan HA; Ghazy MS; Ragab IA
    Eur J Pediatr; 2015 Nov; 174(11):1503-9. PubMed ID: 25982338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promotion of Propranolol Delivery to Hemangiomas by Using Anti-VEGFR Antibody-Conjugated Poly(lactic-co-glycolic acid) Nanoparticles.
    Zhu X; Guo X; Liu D; Gong Y; Sun J; Dong C
    J Biomed Nanotechnol; 2017 Dec; 13(12):1694-1705. PubMed ID: 29490757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary results of propranolol treatment for patients with infantile hemangioma.
    Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
    Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
    Hu L; Zhou B; Huang H; Chang L; Qiu Y; Ma G; Chen H; Jin Y; Xu X; Lin X; Li W
    J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined oral propranolol with intralesional injection of triamcinolone acetonide in treatment of infantile periocular hemangiomas.
    Alsmman AH; Mounir A
    Clin Ophthalmol; 2017; 11():2177-2181. PubMed ID: 29263646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial.
    Bauman NM; McCarter RJ; Guzzetta PC; Shin JJ; Oh AK; Preciado DA; He J; Greene EA; Puttgen KB
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):323-30. PubMed ID: 24526257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Propranolol in the treatment of problematic infantile hemangiomas].
    Lu J; Qin G; Huang J; Li S; Zhao J; Xiang Y; Chen J; Zuo C; Yang S; Tna L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1102-5. PubMed ID: 22169728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infantile Sacral Region Hemangioma and Combination Treatment with Propranolol and Topical Timolol: Case Review and Reference Review.
    Kardasevic M; Dinarevic SM
    Med Arch; 2021 Apr; 75(2):158-161. PubMed ID: 34219878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth characteristics of infantile hemangiomas: implications for management.
    Chang LC; Haggstrom AN; Drolet BA; Baselga E; Chamlin SL; Garzon MC; Horii KA; Lucky AW; Mancini AJ; Metry DW; Nopper AJ; Frieden IJ;
    Pediatrics; 2008 Aug; 122(2):360-7. PubMed ID: 18676554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
    Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
    J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.